UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

C-MET as a potential target therapy toward personalized therapy in some pediatric tumors: An overview

Critical reviews in oncology/hematology, 2018-11, Vol.131, p.7-15

Rashed, Wafaa M.

2018

Volltextzugriff (PDF)

Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma

Journal of pharmaceutical and biomedical analysis, 2024-03, Vol.240, p.115962, Article 115962

2024

Volltextzugriff (PDF)

Novel olive oil phenolic (−)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities

International journal of pharmaceutics, 2019-10, Vol.569, p.118596-118596, Article 118596

2019

Volltextzugriff (PDF)

Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity

Cell death & disease, 2013-10, Vol.4 (10), p.e871-e871

2013

Volltextzugriff (PDF)

hTID-1 defines a novel regulator of c-Met Receptor signaling in renal cell carcinomas

Oncogene, 2011-05, Vol.30 (19), p.2252-2263

2011

Volltextzugriff (PDF)

C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes

Cancer biology & therapy, 2008-06, Vol.7 (6), p.856-863

2008

Volltextzugriff (PDF)

Review of clinic trials: agents targeting c-Met

Reviews on recent clinical trials, 2007-05, Vol.2 (2), p.143-147

2007

Volltextzugriff (PDF)

Evidence for the Identity of Human Scatter Factor and Human Hepatocyte Growth Factor

Proceedings of the National Academy of Sciences - PNAS, 1991-08, Vol.88 (16), p.7001-7005

1991

Volltextzugriff (PDF)

Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies

Journal of gastroenterology and hepatology, 2001-04, Vol.16 (4), p.363-372

2001

Volltextzugriff (PDF)

Biological Role of the HGF/MET Ligand/Receptor Couple in Bovine Mammary Epithelial Cells

Veterinary research communications, 2007-08, Vol.31 (S1), p.161-164

2007

Volltextzugriff (PDF)

Genetic Insights into Endothelial Barrier Regulation in the Acutely Inflamed Lung

The Pulmonary Endothelium, 2009, p.399-415

2009

Volltextzugriff (PDF)

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

Nature communications, 2019-09, Vol.10 (1), p.4343-13, Article 4343

2019

Volltextzugriff (PDF)

Hepatocyte growth factor/MET in cancer progression and biomarker discovery

Cancer science, 2017-03, Vol.108 (3), p.296-307

2017

Volltextzugriff (PDF)

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Nature genetics, 2012-08, Vol.44 (8), p.852-860

2012

Volltextzugriff (PDF)

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Oncogene, 2016-05, Vol.35 (21), p.2687-2697

2016

Volltextzugriff (PDF)

Safety and Tolerability of c-MET Inhibitors in Cancer

Drug safety, 2019-02, Vol.42 (2), p.211-233

2019

Volltextzugriff (PDF)

The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study

Cell chemical biology, 2018-01, Vol.25 (1), p.67-77.e3

2018

Volltextzugriff (PDF)

Preclinical Rationale for Use of the Clinically Available Multitargeted Tyrosine Kinase Inhibitor Crizotinib in ROS1-Translocated Lung Cancer

Journal of thoracic oncology, 2012-07, Vol.7 (7), p.1086-1090

2012

Volltextzugriff (PDF)

Dysregulation of Wnt/β‐catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application

Cancer science, 2021-05, Vol.112 (5), p.1695-1706

2021

Volltextzugriff (PDF)

Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance

Clinical cancer research, 2018-07, Vol.24 (13), p.3108-3118

2018

Volltextzugriff (PDF)

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

Oncogene, 2009-08, Vol.28 (Suppl 1), p.S24-S31

Gazdar, A F

2009

Volltextzugriff (PDF)

Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma

Oncogene, 2012-11, Vol.31 (46), p.4859-4867

2012

Volltextzugriff (PDF)

The race to target MET exon 14 skipping alterations in non-small cell lung cancer: the Why, the How, the Who, the Unknown, and the Inevitable

Lung cancer (Amsterdam, Netherlands), 2017-01, Vol.103, p.27-37

2017

Volltextzugriff (PDF)

An overview of the c-MET signaling pathway

Therapeutic Advances in Medical Oncology, 2011-11, Vol.3 (1_suppl), p.S7-S19

2011

Volltextzugriff (PDF)

1 – 25 von 1.690

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.617)
Mit Volltextzugriff
(1.534)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.533)
Life Sciences & Biomedicine
(1.387)
Humans
(1.195)
C-Met Protein
(699)
Oncology
(696)
Animals
(676)
Kinases
(614)
Tumors
(486)
Proto-Oncogene Proteins C-Met - Metabolism
(483)
Mutation
(438)
Protein-Tyrosine Kinase Receptors
(400)
Biochemistry & Molecular Biology
(392)
Proto-Oncogene Proteins C-Met
(390)
Signal Transduction
(388)
Proto-Oncogene Proteins C-Met - Genetics
(385)
Mice
(384)
Female
(380)
Tyrosine
(378)
Cell Line, Tumor
(350)
Phosphorylation
(350)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.424)
EZB Electronic Journals Library
(1.132)
IngentaConnect
(752)
Ovid SocietyJournals and Single Titles
(579)
IngentaConnect Journals
(395)
Publisher or Other Site
(364)
Wiley HSS Collection
(247)
Elsevier ScienceDirect Journals Complete
(241)
Nature Journals
(225)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(184)
Springer journals
(183)
Nexis Uni
(174)
Wiley Online Library Full Collection 2018
(164)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(95)
Taylor & Francis Journals
(59)
JSTOR All Journals
(55)
Taylor & Francis 数据库
(49)
Springer Book Series
(36)
Taylor & Francis Journals Complete
(35)
Oxford journals
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

C-MET as a potential target therapy toward personalized therapy in some pediatric tumors: An overview

Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma

Novel olive oil phenolic (−)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities

Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity

hTID-1 defines a novel regulator of c-Met Receptor signaling in renal cell carcinomas

C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes

Review of clinic trials: agents targeting c-Met

Evidence for the Identity of Human Scatter Factor and Human Hepatocyte Growth Factor

Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies

Biological Role of the HGF/MET Ligand/Receptor Couple in Bovine Mammary Epithelial Cells

Genetic Insights into Endothelial Barrier Regulation in the Acutely Inflamed Lung

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

Hepatocyte growth factor/MET in cancer progression and biomarker discovery

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Safety and Tolerability of c-MET Inhibitors in Cancer

The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study

Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy

Preclinical Rationale for Use of the Clinically Available Multitargeted Tyrosine Kinase Inhibitor Crizotinib in ROS1-Translocated Lung Cancer

Dysregulation of Wnt/β‐catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application

Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma

The race to target MET exon 14 skipping alterations in non-small cell lung cancer: the Why, the How, the Who, the Unknown, and the Inevitable

An overview of the c-MET signaling pathway

Suchergebnisse filtern